Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-21 Purchase |
2020-08-25 06:00 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
5,325 | $1.56 | $8,307 | 171,882 (Direct) |
View |
| 2020-08-20 Purchase |
2020-08-24 06:06 am |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
30,000 | $1.58 | $47,400 | 166,557 (Direct) |
View |
| 2020-08-14 Purchase |
2020-08-18 8:28 pm |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
44,843 | $1.6284 | $73,021 | 136,557 (Direct) |
View |
| 2020-08-12 Purchase |
2020-08-14 8:17 pm |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
20,000 | $1.725 | $34,500 | 91,714 (Direct) |
View |
| 2020-06-24 Purchase |
2020-06-25 5:46 pm |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
9,895 | $1.9 | $18,801 | 71,714 (Direct) |
View |
| 2020-05-22 Purchase |
2020-05-26 5:00 pm |
Tracon Pharmaceuticals Inc. | TCON | THEUER CHARLES President and CEO |
10,592 | $1.8994 | $20,119 | 61,819 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-06-11 Option Award(A) |
2020-07-31 9:06 pm |
N/A 2030-06-11 |
Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 4:41 pm |
N/A 2029-06-10 |
Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director |
15,000 | $0 | 15,000 (Direct) |
View |